Vitruvias Therapeutics, Inc. — Form D
Vitruvias Therapeutics, Inc. of AUBURN, AL, a company, filed a Form D exempt-offering notice with the SEC on 2017-12-20. The offering totals $11.5M. Industry: Pharmaceuticals.
Offering
- Filed: 2017-12-20
- Form: D
- Accession: 0001592342-17-000003
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $11.5M
- Remaining: $11.5M
- Minimum investment: $25K
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-301275
Issuer
- Name: Vitruvias Therapeutics, Inc.
- CIK: 0001592342
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2013
- Address: 670 NORTH COLLEGE STREET, AUBURN, AL, 36830
- Phone: 334-329-5601
Officers, directors & promoters (13)
| Name | Role | Location |
|---|
| Roger D Graben | Director | Auburn, AL |
| A Stuart Hendon | Director | Montgomery, AL |
| Thomas A Main | Director | Union Springs, AL |
| Charles T Smith | Director | Florala, AL |
| Bryce M Harvey | Director | Santa Rosa Beach, FL |
| Bryce M Harvey | Executive Officer | Santa Rosa Beach, FL |
| Jason D Wild | Director | New York, NY |
| Roger D Graben | Executive Officer | Auburn, AL |
| Michael D Altman | Director | New York, NY |
| Edward D Schutter | Director | Marietta, GA |
| Carl L Whatley | Director | Auburn, AL |
| Carl L Whatley | Executive Officer | Auburn, AL |
| Carl Leo Whatley, Jr. | Executive Officer | Montgomery, AL |
Other filings by this issuer (4)
More